WO2024213797 - IMIDAZOLE LOADED GLYCYRRHIZIC ACID HYDROGELS
National phase entry:
Publication Number
WO/2024/213797
Publication Date
17.10.2024
International Application No.
PCT/EP2024/060183
International Filing Date
15.04.2024
Title **
[English]
IMIDAZOLE LOADED GLYCYRRHIZIC ACID HYDROGELS
[French]
HYDROGELS D'ACIDE GLYCYRRHIZIQUE CHARGÉS D'IMIDAZOLE
Applicants **
KATHOLIEKE UNIVERSITEIT LEUVEN
KU Leuven Research & Development Waaistraat 6 - Box 5105
3000 Leuven, BE
Inventors
CAMMUE, Bruno
J.B. Woutersstraat 109A
1652 Alsemberg, BE
MEES, Maarten
Smarre 4
9667 Horebeke, BE
STEENACKERS, Hans
Goudsbloemstraat 30
3000 Leuven, BE
THEVISSEN, Karin
Ezelbergstraat 14
3360 Bierbeek, BE
THIELEMANS, Wim
Kapittelstraat 12
8500 Kortrijk, BE
VACKIER, Thijs
Stationsstraat 14
9200 Dendermonde, BE
Priority Data
23168100.8
14.04.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1739 | |
| EPO | Filing, Examination | 11237 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 5910 |
Total: 20052 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present application relates to a glycyrrhizic acid hydrogel with a pH of between 2,5 and 5,0 and comprising an imidazole, for use in the treatment or prevention of a bacterial or fungal infection. The application further relates to a pharmaceutical composition of said hydrogel and a method of treating or preventing a bacterial or fungal infection in an individual comprising the step of administering an effective aammoouunntt of an imidazole in aa glycyrrhizic acid hydrogel, a pharmaceutically acceptable salt or solvate thereof, with a pH of between 2,5 and 5,0.[French]
La présente demande concerne un hydrogel d'acide glycyrrhizique possédant un pH compris entre 2,5 et 5,0 et comprenant un imidazole, destiné à être utilisé dans le traitement ou la prévention d'une infection bactérienne ou fongique. La demande concerne en outre une composition pharmaceutique dudit hydrogel et une méthode de traitement ou de prévention d'une infection bactérienne ou fongique chez un sujet comprenant l'étape d'administration d'une quantité efficace d'un imidazole dans un hydrogel d'acide glycyrrhizique, un sel ou solvate pharmaceutiquement acceptable de celui-ci, avec un pH compris entre 2,5 et 5,0.